Opioid Use Disorder
Conditions
Keywords
contingency management, opioid use disorder, incarceration, reentry
Brief summary
People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community. In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions. Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD. The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.
Interventions
Participants receive gift card rewards for attending MOUD appointments and counseling appointments after release from incarceration.
Sponsors
Study design
Eligibility
Inclusion criteria
* Be adults (age ≥18 years) currently incarcerated at Clatsop County Jail * Be enrolled in the jail's MOUD program at the time of recruitment * Plan to continue MOUD with Clatsop Behavioral Healthcare upon release * Speak English and be able to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients receiving medication for opioid use disorder | 1, 2, and 3 months | We will assess patient reported receipt of medication for opioid use disorder and also use chart review to determine whether patients are receiving medications and three different time points. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of contingency management sessions attended | 3 months | Number of contingency management sessions attended per participant |
| Total contingency management rewards earned | 3 months | Total dollar amount of contingency management rewards earned by participant throughout the intervention |
| Addiction Severity | Baseline and 3 months | Participant reported addiction severity using the validated Brief Addiction Monitor, a 17-item, multidimensional progress monitoring tool designed to support the provision of measurement-based care to patients commencing and matriculating through treatment for substance use disorders (SUD). The BAM items assess: (1) Risk for relapse or worsening severity of SUD (Range 0-180 with higher scores indicating higher risk), (2) Protective behaviors that support recovery and resistance to relapse (Range 0-180 with higher score indicating higher protective factors), and (3) Use of alcohol and other substances (Range 0-90 with higher score indicating higher substance use). |
| Recovery Capital | Baseline and 3 months | Participant reported survey on recovery capital using the validated Brief Assessment of Recovery Capital (BARC-10) survey. Score range 10-60 with higher scores indicating higher recovery capital. |
Countries
United States